Page last updated: 2024-10-30

lansoprazole and Ataxia

lansoprazole has been researched along with Ataxia in 1 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sharif, A1
Carr, L1
Saliakellis, E1
Chakraborty, H1

Other Studies

1 other study available for lansoprazole and Ataxia

ArticleYear
Paroxysmal head drops with ataxia-like symptoms presenting as Sandifer syndrome in a 3-year old girl.
    BMJ case reports, 2020, Mar-04, Volume: 13, Issue:3

    Topics: Ataxia; Child, Preschool; Diagnosis, Differential; Dystonia; Female; Gastroesophageal Reflux; Humans

2020